WaveMan
WaveMan · Company
IVFH · Innovative Food Holdings Inc
> Search tickers & screens ⌘K
LIVE
← All companies

IVFH Innovative Food (IVFH) Insider Trading, Ownership & Congress Trades

Wholesale & Retail · Wholesale-groceries, general line · CIK 0000312257
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

Innovative Food insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for INNOVATIVE FOOD HOLDINGS INC in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
SELL
2026-01-28 SECtraded 2026-01-21
26,000
$11.2K
-64.1%
Context
  • 18 earlier Form 4 trades (code P or S) here by this insider (4 buys, 14 sales), the last on Jan 20, 2026.
  • +10.6% median (+12.5% mean) 90-day return after 4 previous buys.
  • The trade is 6.9% of the 377,571 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Insider Bennett Robert William sold about $11.2K of IVFH on Jan 21, 2026.
SELL
2026-01-28 SECtraded 2026-01-20
2,600
$1.1K
-64.1%
Context
  • 17 earlier Form 4 trades (code P or S) here by this insider (4 buys, 13 sales), the last on Jan 16, 2026.
  • +10.6% median (+12.5% mean) 90-day return after 4 previous buys.
  • The trade is 0.6% of the 403,571 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Insider Bennett Robert William sold about $1.1K of IVFH on Jan 20, 2026.
SELL
2026-01-28 SECtraded 2026-01-16
19,410
$8.3K
-64.1%
Context
  • 15 earlier Form 4 trades (code P or S) here by this insider (4 buys, 11 sales), the last on Jan 15, 2026.
  • +10.6% median (+12.5% mean) 90-day return after 4 previous buys.
  • No other insider sold within 30 days.
Insider activity: Insider Bennett Robert William sold about $8.3K of IVFH on Jan 16, 2026.
SELL
2026-01-28 SECtraded 2026-01-16
22,500
$9.7K
-64.1%
Context
  • 15 earlier Form 4 trades (code P or S) here by this insider (4 buys, 11 sales), the last on Jan 15, 2026.
  • +10.6% median (+12.5% mean) 90-day return after 4 previous buys.
  • The trade is 5.5% of the 406,171 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Insider Bennett Robert William sold about $9.7K of IVFH on Jan 16, 2026.
SELL
2026-01-28 SECtraded 2026-01-15
28,900
$13.3K
-64.1%
Context
  • 14 earlier Form 4 trades (code P or S) here by this insider (4 buys, 10 sales), the last on Jan 14, 2026.
  • +10.6% median (+12.5% mean) 90-day return after 4 previous buys.
  • The trade is 6.7% of the 428,671 shares held after it.
  • No other insider sold within 30 days.
Insider activity: Insider Bennett Robert William sold about $13.3K of IVFH on Jan 15, 2026.
55 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Showing the latest few. to see 50 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+2.1% year over year
below 57% of Wholesale & Retail
Margin
-3.4% net margin
below 74% of Wholesale & Retail
Buybacks
no share repurchases reported
Short interest
<0.1% of the float short (float per yahoo 2026-10-27) · 1.0 days to cover · settled 2026-10-15
the lowest in Wholesale & Retail
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch IVFH

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-62.9%12M
-69%-42%-15%+12%2025-102025-122026-022026-042026-062026-082026-10 2026-01-06 · Bennett Robert William sold $450.0K2026-01-06 · Smith Denver Johnson bought $151.7K2026-01-06 · JCP Investment Management, LLC bought $151.7K2026-01-08 · Bennett Robert William sold $102.7K2026-01-06 · Schmulen Mark bought $86.7K2026-01-06 · Schubert Gary bought $50.0K2026-01-13 · Bennett Robert William sold $30.1K2026-01-09 · Bennett Robert William sold $23.2K2026-01-13 · Bennett Robert William sold $16.4K2026-01-12 · Bennett Robert William sold $16.4K2026-01-15 · Bennett Robert William sold $13.3K2026-01-09 · Bennett Robert William sold $11.7K2026-01-21 · Bennett Robert William sold $11.2K2026-01-16 · Bennett Robert William sold $9.7K2026-01-16 · Bennett Robert William sold $8.3K2026-01-08 · Bennett Robert William sold $7.8K2026-01-14 · Bennett Robert William sold $1.3K2026-01-20 · Bennett Robert William sold $1.1K
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns IVFH: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in IVFH

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

IVFH planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Same sector, ranked by filing activity
Sector by SEC SIC code

IVFH financials

Revenue growth
+2.1%
XBRL, annual
Net margin
-3.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Free cash flow, TTM
$685.5K
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
0.03x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Cash flow to debt
3.00x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Return on equity
+7.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+3.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
+32.1%
operating income after a 4.8% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on capital employed
+17.5%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
4.23x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
$7.4M
market value at close 2026-10-26 on 2026-08-12 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
FCF yield
+7.6%
TTM free cash flow over market value at close 2026-10-26
PEG, trailing
n/a
trailing EPS growth -22%, PEG needs growth
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$60.7M$72.1M$72.2M$80.1M
Gross profit$15.6M$15.0M$17.0M$17.5M
Operating income$2.6M$1.3M-$2.8M-$805.7K
Net income-$2.0M$2.6M-$4.4M-$1.4M
EPS (diluted)0.050.08-0.08-0.02
Operating cash flow-$27.4K-$6.3M-$435.6K-$599.1K
Cash$927.5K$1.3M$5.2M$4.8M
Long-term debt$216.9K$282.8K$8.9M$0
SEC XBRL, fiscal years, as known on 2026-10-28

IVFH Stock Sonar score 4/7 axes

Find similar shapesCompare

IVFH ranks highest on financial health (87th percentile) and risk and compliance (70th), and lowest on growth (43rd), among Wholesale & Retail peers.

Profitability
64
Inputs
  • Return on equity+7.0% · 48 pct, sector of 206
  • Return on assets+3.2% · 55 pct, sector of 257
  • Return on invested capital+32.1% · 78 pct, sector of 109
  • Return on capital employed+17.5% · 76 pct, sector of 220
Financial health
87
Inputs
  • Debt to equity0.03x · 81 pct, sector of 222
  • Cash flow to debt3.00x · 92 pct, sector of 210
Growth
43
Inputs
  • Revenue growth, YoY+2.1% · 43 pct, sector of 311
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
70
Inputs
  • Short interest, % of float+0.0% · 100 pct, sector of 317
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 242
  • New text in Risk Factors, latest 10-K+27.7% · 11 pct, sector of 226
3 not measured: Insider conviction, Institutional and government, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing